MS therapies in pediatric patients with refractory MS
MS therapies in pediatric patients with refractory MS
Background: Currently available disease-modifying therapies (DMTs) are known to be only partially effective in adults with multiple sclerosis (MS). Little is known about pediatric patients with MS who experience refractory disease while receiving first-line DMTs.
Objective
To assess the occurrence and management of refractory disease in a group of pediatric patients with MS treated with first-line DMTs approved for adult patients within a network of pediatric MS centers in the United States.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1408
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 890 Views
-
Last post by jimmylegs
-
- 0 Replies
- 701 Views
-
Last post by NHE
-
- 0 Replies
- 936 Views
-
Last post by NHE
-
- 0 Replies
- 1139 Views
-
Last post by frodo
-
- 0 Replies
- 1019 Views
-
Last post by Petr75
-
- 0 Replies
- 1890 Views
-
Last post by NHE
-
- 0 Replies
- 1332 Views
-
Last post by DIM
-
- 0 Replies
- 1334 Views
-
Last post by frodo
-
- 0 Replies
- 1369 Views
-
Last post by NHE